Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | CHEK2 |
Variant | N290Ifs*15 |
Impact List | frameshift |
Protein Effect | loss of function - predicted |
Gene Variant Descriptions | CHEK2 N290Ifs*15 indicates a shift in the reading frame starting at amino acid 290 and terminating 15 residues downstream causing a premature truncation of the 543 amino acid Chek2 protein (UniProt.org). N290Ifs*15 has not been characterized, however, due to the effects of other truncation mutations downstream of N290 resulting in disruption of the protein kinase domain (PMID: 11053450, PMID: 16982735, PMID: 31050813), is predicted to lead to a loss of Chek2 protein function. |
Associated Drug Resistance | |
Category Variants Paths |
CHEK2 mutant CHEK2 inact mut CHEK2 N290Ifs*15 |
Transcript | NM_007194.3 |
gDNA | chr22:g.28703545_28703546insAT |
cDNA | c.868_869insTA |
Protein | p.N290Ifs*15 |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_007194.3 | chr22:g.28703545_28703546insAT | c.868_869insTA | p.N290Ifs*15 | RefSeq | GRCh38/hg38 |
NM_145862.2 | chr22:g.28703545_28703546insAT | c.868_869insTA | p.N290Ifs*15 | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|